Drug abuse in Pakistan - United Nations Office on Drugs and Crime
Drug abuse in Pakistan - United Nations Office on Drugs and Crime Drug abuse in Pakistan - United Nations Office on Drugs and Crime
DRUG ABUSE IN PAKISTAN This suggests that whilst considerable difficulties may exist
INTERVIEWS WITH DRUG ABUSERS Figure V. Usual route of hero
- Page 1 and 2: Supported by the UNDCP Global Asses
- Page 3 and 4: UNITED NATIONS OFFICE FOR DRUG CONT
- Page 5 and 6: Acknowledgements The National <stro
- Page 7 and 8: Contents Acknowledgements . . . . .
- Page 9 and 10: 3. Respondents’ perceptions of th
- Page 11 and 12: Executive summary The Pakis
- Page 13 and 14: EXECUTIVE SUMMARY About half of tho
- Page 15: EXECUTIVE SUMMARY on these groups c
- Page 18 and 19: DRUG ABUSE IN PAKISTAN data are to
- Page 20 and 21: DRUG ABUSE IN PAKISTAN at the time
- Page 22 and 23: DRUG ABUSE IN PAKISTAN Act also all
- Page 25: 2 Rationale, methods and sampl<stro
- Page 28 and 29: DRUG ABUSE IN PAKISTAN (19 urban an
- Page 30 and 31: DRUG ABUSE IN PAKISTAN Table 3. Res
- Page 32 and 33: DRUG ABUSE IN PAKISTAN associated w
- Page 34 and 35: DRUG ABUSE IN PAKISTAN Table 7. Per
- Page 36 and 37: DRUG ABUSE IN PAKISTAN Perceptions
- Page 38 and 39: DRUG ABUSE IN PAKISTAN decl
- Page 40 and 41: DRUG ABUSE IN PAKISTAN in</
- Page 42 and 43: DRUG ABUSE IN PAKISTAN Table 14. Me
- Page 46 and 47: DRUG ABUSE IN PAKISTAN Respondents
- Page 49 and 50: 5 Drug in<
- Page 51 and 52: DRUG INJECTING in
- Page 53 and 54: DRUG INJECTING Lahore profile In La
- Page 55: DRUG INJECTING unemployed, compared
- Page 58 and 59: DRUG ABUSE IN PAKISTAN In P
- Page 60 and 61: DRUG ABUSE IN PAKISTAN procedures f
- Page 62 and 63: DRUG ABUSE IN PAKISTAN National tre
- Page 65 and 66: 8 National drug contour mapp<strong
- Page 67 and 68: NATIONAL DRUG CONTOUR MAPPING Table
- Page 69 and 70: NATIONAL DRUG CONTOUR MAPPING Figur
- Page 71 and 72: NATIONAL DRUG CONTOUR MAPPING Table
- Page 73 and 74: NATIONAL DRUG CONTOUR MAPPING Table
- Page 75 and 76: 9 Drug abu
- Page 77 and 78: IMPLICATIONS OF THE NATIONAL ASSESS
- Page 79: IMPLICATIONS OF THE NATIONAL ASSESS
- Page 82 and 83: DRUG ABUSE IN PAKISTAN different as
- Page 84 and 85: DRUG ABUSE IN PAKISTAN offences for
- Page 86 and 87: DRUG ABUSE IN PAKISTAN This approac
- Page 88 and 89: DRUG ABUSE IN PAKISTAN Table A.II.1
- Page 90 and 91: DRUG ABUSE IN PAKISTAN Table A.II.4
- Page 92 and 93: DRUG ABUSE IN PAKISTAN Table A.II.6
INTERVIEWS WITH DRUG ABUSERS<br />
Figure V.<br />
Usual route of hero<str<strong>on</strong>g>in</str<strong>on</strong>g><br />
adm<str<strong>on</strong>g>in</str<strong>on</strong>g>istrati<strong>on</strong><br />
Inject<br />
drug <strong>on</strong> a daily basis. It appears that overall the<br />
users of these drugs are comprised of both a group<br />
of <str<strong>on</strong>g>in</str<strong>on</strong>g>tensive users <strong>and</strong> a significant, but slightly<br />
smaller proporti<strong>on</strong>, of occasi<strong>on</strong>al users.<br />
Smoke<br />
Sniff<br />
The mean number of days <strong>on</strong> which hero<str<strong>on</strong>g>in</str<strong>on</strong>g> was c<strong>on</strong>sumed<br />
(27) <str<strong>on</strong>g>in</str<strong>on</strong>g>dicates that hero<str<strong>on</strong>g>in</str<strong>on</strong>g> use was be<str<strong>on</strong>g>in</str<strong>on</strong>g>g more<br />
<str<strong>on</strong>g>in</str<strong>on</strong>g>tensively used by resp<strong>on</strong>dents than the other psychoactive<br />
substances listed. Most (77%) of those<br />
who were us<str<strong>on</strong>g>in</str<strong>on</strong>g>g hero<str<strong>on</strong>g>in</str<strong>on</strong>g> reported us<str<strong>on</strong>g>in</str<strong>on</strong>g>g the drug <strong>on</strong><br />
a daily basis <str<strong>on</strong>g>in</str<strong>on</strong>g> the m<strong>on</strong>th prior to <str<strong>on</strong>g>in</str<strong>on</strong>g>terview. This<br />
figure was highest for the street users where 86%<br />
reported daily use as compared to 75% of treatment<br />
attendees <strong>and</strong> 69% of the pris<strong>on</strong> sample. Just over<br />
6% of subjects where us<str<strong>on</strong>g>in</str<strong>on</strong>g>g hero<str<strong>on</strong>g>in</str<strong>on</strong>g> <strong>on</strong> a <strong>on</strong>ce per<br />
week basis or less. Overall these data suggest that<br />
a highly dependent, chr<strong>on</strong>ic hero<str<strong>on</strong>g>in</str<strong>on</strong>g> abus<str<strong>on</strong>g>in</str<strong>on</strong>g>g populati<strong>on</strong><br />
has been accessed by this study.<br />
Far fewer <str<strong>on</strong>g>in</str<strong>on</strong>g>dividuals were us<str<strong>on</strong>g>in</str<strong>on</strong>g>g synthetic opiates<br />
but of these just over half (57%) were do<str<strong>on</strong>g>in</str<strong>on</strong>g>g so <strong>on</strong><br />
an <str<strong>on</strong>g>in</str<strong>on</strong>g>tensive basis (four times a week or more).<br />
Intensive users of synthetic opiates were more comm<strong>on</strong><br />
am<strong>on</strong>gst the sample of street addicts. Although<br />
morph<str<strong>on</strong>g>in</str<strong>on</strong>g>e was <strong>on</strong>ly c<strong>on</strong>sumed by a very small number<br />
of subjects, two-thirds of these were us<str<strong>on</strong>g>in</str<strong>on</strong>g>g the<br />
Daily use of hashish was also comm<strong>on</strong> with 41% of<br />
those us<str<strong>on</strong>g>in</str<strong>on</strong>g>g this drug report<str<strong>on</strong>g>in</str<strong>on</strong>g>g daily use <str<strong>on</strong>g>in</str<strong>on</strong>g> the<br />
m<strong>on</strong>th prior to <str<strong>on</strong>g>in</str<strong>on</strong>g>terview, a further 34% were us<str<strong>on</strong>g>in</str<strong>on</strong>g>g<br />
more occasi<strong>on</strong>ally <strong>and</strong> reported 10 days of use or<br />
less <str<strong>on</strong>g>in</str<strong>on</strong>g> this period. Of those c<strong>on</strong>sum<str<strong>on</strong>g>in</str<strong>on</strong>g>g opium most<br />
(32%) were us<str<strong>on</strong>g>in</str<strong>on</strong>g>g the drug regularly <strong>on</strong> five days a<br />
week or more. The c<strong>on</strong>sumpti<strong>on</strong> of alcohol was more<br />
varied but nearly all resp<strong>on</strong>dents (76%) who drank<br />
were dr<str<strong>on</strong>g>in</str<strong>on</strong>g>k<str<strong>on</strong>g>in</str<strong>on</strong>g>g <strong>on</strong> two or three days a week or less<br />
with <strong>on</strong>ly 10% five or more days a week.<br />
In additi<strong>on</strong> to <str<strong>on</strong>g>in</str<strong>on</strong>g>tensity of use, the route of adm<str<strong>on</strong>g>in</str<strong>on</strong>g>istrati<strong>on</strong><br />
(the way the drug is taken by the c<strong>on</strong>sumer)<br />
can be an important factor <str<strong>on</strong>g>in</str<strong>on</strong>g> <str<strong>on</strong>g>in</str<strong>on</strong>g>fluenc<str<strong>on</strong>g>in</str<strong>on</strong>g>g the amount<br />
of morbidity <strong>and</strong> mortality that results from a given<br />
level of prevalence. Data <strong>on</strong> the usual route of<br />
adm<str<strong>on</strong>g>in</str<strong>on</strong>g>istrati<strong>on</strong> for drugs data is presented <str<strong>on</strong>g>in</str<strong>on</strong>g><br />
table 17. It should be noted that these data reflect<br />
the most comm<strong>on</strong> rather than an exclusive practice.<br />
For many drug types, <str<strong>on</strong>g>in</str<strong>on</strong>g>clud<str<strong>on</strong>g>in</str<strong>on</strong>g>g hero<str<strong>on</strong>g>in</str<strong>on</strong>g>, drug <str<strong>on</strong>g>in</str<strong>on</strong>g>jecti<strong>on</strong><br />
is the route of adm<str<strong>on</strong>g>in</str<strong>on</strong>g>istrati<strong>on</strong> typically thought<br />
of as result<str<strong>on</strong>g>in</str<strong>on</strong>g>g <str<strong>on</strong>g>in</str<strong>on</strong>g> the greatest levels of morbidity <strong>and</strong><br />
mortality. In particular, this method of use is associated<br />
with the transiti<strong>on</strong> of HIV <strong>and</strong> other blood<br />
borne diseases <strong>and</strong> has also been associated with<br />
the elevated risk of opioid overdose. The <str<strong>on</strong>g>in</str<strong>on</strong>g>jecti<strong>on</strong><br />
of drugs is therefore c<strong>on</strong>sidered aga<str<strong>on</strong>g>in</str<strong>on</strong>g> <str<strong>on</strong>g>in</str<strong>on</strong>g> detail later<br />
<str<strong>on</strong>g>in</str<strong>on</strong>g> this secti<strong>on</strong>.<br />
Table 17.<br />
Route of adm<str<strong>on</strong>g>in</str<strong>on</strong>g>istrati<strong>on</strong> (selected drugs <strong>on</strong>ly—percentage of whole sample)<br />
<str<strong>on</strong>g>Drug</str<strong>on</strong>g> Swallow Snort/sniff Smoke Inject<br />
Hashish/charas 4 96<br />
Hero<str<strong>on</strong>g>in</str<strong>on</strong>g>